Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06494033 · ClinicalTrials.gov registry record
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
A clinical trial of Lung Diseases, sponsored by University of Miami.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06494033 is a study of Lung Diseases that is actively recruiting participants, run by University of Miami. The registered enrollment target is 100 participants, below the 736-participant average among 31 other Lung Diseases trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06494033, a study of Lung Diseases, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the clinical outcomes of Cytomegalovirus (CMV) virus in the participants' body. Therefore, the study team will follow the participants' immunological response based on the Cytomegalovirus (CMV) virus testing.
Conditions Studied
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-07-03 |
| Est. Completion | 2026-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06494033
The ClinicalTrials.gov registry entry for NCT06494033 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 736-participant average among 31 other Lung Diseases trials with a reported enrollment target (86% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT06494033 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06494033 about?
NCT06494033 is a clinical study titled "Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients". The purpose of this study is to evaluate the clinical outcomes of Cytomegalovirus (CMV) virus in the participants' body. Therefore, the study team will follow the participants' immunological response based on the Cytomegalovirus (CMV) virus testing.
What is the current status of trial NCT06494033?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-07-03. Estimated completion is 2026-12-30.
What conditions does trial NCT06494033 study?
This clinical trial studies the following conditions: Lung Diseases.
Who is sponsoring clinical trial NCT06494033?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06494033 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RECRUITING · Phase 2
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
American Lung Association (ALA) Lung Health Cohort
RECRUITING
-
Data Collection Using Eko Digital Devices in a Clinical Setting
RECRUITING
-
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RECRUITING · Phase 2
-
Deep Functional Phenotyping of the ALA Lung Health Cohort
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.